Access to Medicines Related News
Medicines for Europe: better access, better health
Medicines for Europe president Marc-Alexander Mahl outlines the challenges facing the generic, biosimilar and value-added medicines industry and its role in achieving sustainable healthcare.
Medicines...
European Medicines Agency prepares pharmaceutical companies for Brexit
The European Medicines Agency (EMA) and the European Commission have updated their guidance which will help pharmaceutical companies prepare for the UK’s withdrawal from...
Pioneering medical treatments should be available on NHS, survey reveals
New potentially life-saving and pioneering medical treatments such as bone marrow transplant and stem cell therapy should be made available on the National Health...
Health payments causing poverty, even in high-income countries
The costly nature of health payments is unaffordable and causes financial strain to the point of poverty, even in high-income countries, according to a...
New 2018 European guidelines for treatment of arterial hypertension
A first look at the new European Society of Cardiology (ESC) and European Society of Hypertension (ESH) Joint Guidelines for the Management of Arterial...
Antibody therapy for migraine prevention set for marketing authorisation
The first monoclonal antibody therapy for migraine prevention, Aimovig, has been recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal...
Trial launches to test new treatment combination for leukaemia patients
A clinical trial testing a new treatment combination for children and adults with leukaemia has been launched today through the Combinations Alliance.
The aim of...
Can antidepressants increase the risk of weight gain?
A new study published in The BMJ today has found that long term use of antidepressants is linked to the increase in risk of...
European Commission approves single pill for HIV-1 treatment
The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...
NHS funding could hinder patient’s access to drugs warns King’s Fund
A new report from The King’s Fund has revealed that NHS funding levels are not keeping pace with growth in NHS spending on medicines,...
UK asthma death rates among worst in Europe
New analysis from Asthma UK has revealed that the UK is one of the worst places in Europe for asthma death rates, with the...
Three new medicines recommended for approval
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) have recommended three new medicines for approval that will treat numerous...
Common heartburn drug linked to pneumonia in older adults
Pneumonia development in older adults has been found to have a link with the consumption of a group of certain medicines commonly used to...
Cause and effect: learning from error to improve patient safety
At the 6th Annual World Patient Safety, Science & Technology Summit in February 2018, London, UK, HEQ saw Sir Liam Donaldson discuss the importance...
Irish Pharmaceutical Healthcare Association: accessing new medicines
Oliver O’Connor, of the Irish Pharmaceutical Healthcare Association, reflects on efforts to ensure timely access to new and innovative medicines for all patients in...
